Hervé Avet-Loiseau

News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me

Hervé Avet-Loiseau
Dec 1, 2024, 20:24 | Opinion
Vincent Rajkumar's Top 5 ASH24 myeloma abstracts
Vincent Rajkumar, Professor of Medicine at the Mayo Clinic in Rochester, shared a post on X:…
Nov 22, 2024, 11:03 | Insight
Myeloma Paper of the Day, November 22nd, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: Hyperdiploidy (HD) happens after somatic…
Nov 16, 2024, 16:45 | Insight
Myeloma Paper of the Day, November 16th, suggested by Robert Orlowski
Robert Orlowski shared a post on X: “Myeloma Paper of the Day: IFM 2014-01 study of Ixazomib/pom/dex…
Aug 1, 2024, 04:58 | Insight
Real-world data to describe myeloma management and outcomes
Mohamad Mohty, Head of the Clinical Hematology and Cellular Therapy Department at Saint-Antoine Hospital, Sorbonne…
Jun 20, 2024, 13:18 | Insight
Myeloma Paper of the Day, June 20th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Long-term follow-up of Phase III…
Jun 20, 2024, 12:25 | Insight
Luciano Costa: Some considerations on long-term follow-up of the CASSIOPEIA trial
Luciano Costa, a Professor at the University of Alabama at Birmingham, recently shared a post…
Jun 15, 2024, 13:48 | Insight
Myeloma Paper of the Day, June 15th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Natural killer cells with adhesion…
Jun 4, 2024, 14:44 | Insight
Myeloma Paper of the Day, June 4th, suggested by Robert Orlowski
Robert Orlowski shared on X: "Myeloma Paper of the Day: Phase III BENEFIT trial shows…
All: 8 Posts: 1 - 100
Special Coverage